Actively Recruiting

Age: 18Years - 100Years
All Genders
NCT04573062

Natural History of Post-Coronavirus Disease 19 Convalescence at the National Institutes of Health

Led by National Institute of Neurological Disorders and Stroke (NINDS) · Updated on 2026-03-13

1590

Participants Needed

1

Research Sites

312 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Background: People who get COVID-19 have a wide range of symptoms. They also recover from COVID-19 in different ways. In this study, researchers will use survey data to describe the different ways people experience and recover from COVID-19. They will also use the data to help create future studies to understand why some people do not fully recover. Objective: To learn more about the range and timing of symptoms that people have before, during, and after COVID-19 infection. Eligibility: People ages 18 and older who can give documentation of a positive COVID-19 or antibody test. Design: Participants will be screened with a telephone interview. It will take 15 minutes. They will provide their COVID-19 test results and medical records. Participants will complete a second telephone interview. It will take 30 60 minutes. They will also take online surveys every 3 months for 3 years. The interview and surveys will ask participants about their health before they got COVID-19, what happened while they had COVID-19, and what their recovery has been like. Participants will get log-in data to take the online surveys. Completing all of the surveys the first time may take up to 3 hours. Follow-up surveys will take up to 30 minutes. Participants do not have to complete the surveys in one sitting. They will be able to save their progress and finish the surveys later. Participants may be contacted to take part in other research studies.

CONDITIONS

Official Title

Natural History of Post-Coronavirus Disease 19 Convalescence at the National Institutes of Health

Who Can Participate

Age: 18Years - 100Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Participants 18 years or older
  • Ability to provide informed consent
  • Willingness to complete telephone interviews
  • Started recovery from acute SARS/CoV2 infection within the past 5 years or meet specific criteria for persistent symptoms or vaccine-related conditions
  • Provide documentation of positive COVID-19 test or clinical diagnosis as applicable
  • For Phase B: completion of at least 7th grade, fluency in English, primary care provider, at least 6 weeks since symptom onset, no active infection
  • Meet criteria for mild to moderate COVID-19 illness with varying severity of post-acute symptoms as defined in study
  • For Phase C: meet Phase B criteria and no alternative explanation for symptoms, fluency in English
Not Eligible

You will not qualify if you...

  • Unwillingness to provide personal identifying information
  • Severe cognitive impairment limiting consent capacity
  • Current or past psychotic disorders
  • Unmanaged major depression, anxiety, PTSD, panic disorder, or OCD within 6 months
  • Substance use disorder in last 5 years except marijuana
  • Positive urine drug screen for non-prescribed substances (some exceptions)
  • Current suicidal thoughts
  • History of moderate or severe traumatic brain injury
  • Pregnant, breastfeeding, or within one year postpartum
  • Current or previous malignancy except fully resolved by surgery only
  • Systemic immunologic disorders (some exceptions)
  • Long-term immune suppressive therapy
  • Medical conditions causing fatigue or exercise intolerance that exclude Phase C participation
  • Participation in other clinical studies affecting results
  • Unwillingness to share data broadly
  • NIH employees under direct supervision of study investigators
  • Symptom severity preventing travel to NIH

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

National Institutes of Health Clinical Center

Bethesda, Maryland, United States, 20892

Actively Recruiting

Loading map...

Research Team

A

Angelique A Gavin

CONTACT

B

Brian T Walitt, M.D.

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here